| Structure | Chemical Name | CAS | MF |
|
2,3-DIHYDRO-6-ISOTHIOCYANATO-1,4-PHTHALAZINEDIONE
|
107807-39-6
|
C9H5N3O2S
|
|
pyroglutamyl-((N3)-imidazolylmethyl)-histidyl-n-amylprolinamide
|
107810-09-3
|
|
|
pyroglutamyl-histidyl-proline-tyramine
|
107810-10-6
|
C24H30N6O5
|
|
Benzaldehyde, 4-Methoxy-2-(1-Methylethoxy)-
|
107811-48-3
|
C11H14O3
|
|
(4R,5E,9E)-3a,4,7,8,11,11aβ-Hexahydro-4α-hydroxy-6,10-dimethyl-3-(morpholinomethyl)cyclodeca[b]furan-2(3H)-one
|
107811-55-2
|
C19H29NO4
|
|
polyisohexylcyanoacrylate
|
107811-81-4
|
C10H15NO2
|
|
1,3-Benzenedicarboxylic acid, dimethyl ester, polymer with 1,4-butanediol, dimethyl 1,4-benzenedicarboxylate and .alpha.-hydro-.omega.-hydroxypoly(oxy-1,4-butanediyl), block
|
107811-95-0
|
(C10H10O4.C10H10O4.C4H10O2.(C4H8O)nH2O)x
|
|
guayulin C
|
107812-57-7
|
C24H30O3
|
|
guayulin D
|
107812-58-8
|
C23H30O4
|
|
Amlodipine Impurity 26
|
107812-86-2
|
C18H19Cl2NO4
|
|
AMbroxol EP IMpurity D
|
107814-37-9
|
C13H18Br2N2O
|
|
preproatrial natriuretic factor (26-55)
|
107814-70-0
|
|
|
preproatrial natriuretic factor (104-123)
|
107814-71-1
|
C94H171N31O28
|
|
5-AMINO-4-CYANO-N,N-DIETHYL-3-METHYLTHIOPHENE-2-CARBOXAMIDE
|
107815-98-5
|
C11H15N3OS
|
|
tricrozarin A
|
107817-60-7
|
C13H10O8
|
|
THIENO(3 2-B)PYRIDIN-7-OL
|
107818-20-2
|
C7H5NOS
|
|
methyl 3-amino-5-(2-chlorophenyl)thiophene-2-carboxylate
|
107818-29-1
|
C12H10ClNO2S
|
|
3-Amino-5-bromo-thiophene-2-carboxylic acid methyl ester
|
107818-55-3
|
C6H6BrNO2S
|
|
1,3-DI-BOC-2-METHYLISOTHIOUREA
|
107819-90-9
|
C12H22N2O4S
|
|
poly(d(Tm(5)C)).poly(d(GA)).poly(d(m(5)CT))
|
107824-41-9
|
C60H88N20O40P6
|
|
NCO I
|
107824-63-5
|
|
|
Ethanethione, 2-(4-fluorophenyl)-1-(4-Morpholinyl)-
|
107825-27-4
|
C12H14FNOS
|
|
Etoricoxib Impurity 39
|
107825-28-5
|
C13H17NOS2
|
|
obelmycin F
|
107826-16-4
|
C40H53NO15
|
|
obelmycin E
|
107826-17-5
|
C40H53NO14
|
|
2-Ethyl-2-methyl-decanoic acid
|
107827-68-9
|
C13H26O2
|
|
5-Dodecanoylaminofluorescein
|
107827-77-0
|
C32H35NO6
|
|
POLY(2-CHLOROSTYRENE)
|
107830-52-4
|
C8H7Cl
|
|
YM 212
|
107831-14-1
|
C22H32N2O4
|
|
1OH-Pyrido(3,2-d)thieno(3,2-e)(1,4)-diazepin-10-one, 4,9-dihydro-4-((4 -methyl-1-piperazinyl)acetyl)-, monohydrochloride
|
107831-45-8
|
C17H19N5O2S.ClH
|
|
H-Val-CMK·HCl
|
107831-79-8
|
C6H12ClNO.ClH
|
|
(R)-(1-PHENYLETHYL)SUCCINATE
|
107832-33-7
|
C12H14O4
|
|
3-Nitropropanaldiethylacetal
|
107833-73-8
|
C7H15NO4
|
|
3-NITROPROPYL 2-TETRAHYDROPYRANYL ETHER
|
107833-76-1
|
C8H15NO4
|
|
Nicorandil N-Oxide
|
107833-98-7
|
C8H9N3O5
|
|
3-THIOPHEN-2-YL-BENZALDEHYDE
|
107834-03-7
|
C11H8OS
|
|
2,3-dihydro-2-Methyl-1H-Isoindole-5-carboxaldehyde
|
107834-36-6
|
C10H11NO
|
|
5-bromo-2-methylisoindoline
|
107834-37-7
|
C9H10BrN
|
|
4,6-dichloronicotinoyl chloride
|
107836-75-9
|
C6H2Cl3NO
|
|
7-(6-O-(5-carboxypentyl)-3,4-dideoxyhex-3-enopyranosyl-2-ulose)theophylline
|
107838-94-8
|
C19H24N4O7
|
|
7-(3,4-dideoxy-6-O-(6-hydroxyhexyl)hex-3-enopyranosyl-2-ulose)theophylline
|
107838-98-2
|
C19H26N4O6
|
|
(E)-3-AMINO-3-(4-CHLOROPHENYL)-2-PROPENENITRILE
|
107840-43-7
|
C9H7ClN2
|
|
rel-(1R,2R)-2-Phenylcyclobutanecarboxylic acid
|
107841-64-5
|
C11H12O2
|
|
5-Amino-1-(3-chlorophenyl)-3-methyl-1H-pyrazole-4-carbonitrile
|
107842-57-9
|
C11H9ClN4
|
|
5-Amino-3-methyl-1-(3-nitrophenyl)-1H-pyrazole-4-carbonitrile
|
107842-58-0
|
C11H9N5O2
|
|
4-Amino-3-bromo-2-hydroxypyridine
|
107842-74-0
|
C5H5BrN2O
|
|
Caffeic Acid Benzyl Ester
|
107843-77-6
|
C16H14O4
|
|
Tetrachlorodimethoxy-1,1'-biphenyl
|
107843-95-8
|
|
|
Pentachlorodimethoxy-1,1'-biphenyl
|
107843-96-9
|
|
|
Ethanone, 1-[4-(1-methylethyl)bicyclo[3.1.0]hex-3-en-1-yl]- (9CI)
|
107844-06-4
|
C11H16O
|
|
POLY(VINYL ALCOHOL), N-METHYL-4(4'-FORMYLSTYRYL)PYRIDINIUM METHOSULFATE ACETAL
|
107845-59-0
|
C18H21NO6S
|
|
BROMOCHLORODIMETHYLHYDANTOIN
|
107846-11-7
|
|
|
3-(3-Fluorophenyl)propenoic acid, 2-(diethoxyphosphinyl)-, ethyl ester
|
107846-68-4
|
C15H20FO5P
|
|
3-(3-Chlorophenyl)propenoic acid, 2-(diethoxyphosphinyl)- ethyl ester
|
107846-69-5
|
C15H20ClO5P
|
|
β-Hydroxy Thyroxine
|
107849-54-7
|
C15H11I4NO5
|
|
Cerkocid
|
107852-19-7
|
|
|
POLY(TETRAFLUOROETHYLENE OXIDE-CO-DIFLUOROMETHYLENE OXIDE) ALPHA,OMEGA-BIS(METHYL CARBOXYLATE)
|
107852-49-3
|
C6H8F8O7
|
|
FOMBLIN-Z DISOC)
|
107852-50-6
|
|
|
FLUOROLINK(R) D
|
107852-51-7
|
|
|
cytomegalovirus phosphoprotein 71kDa
|
107852-97-1
|
|
|
PHO2 regulatory protein (Sacch cerev)
|
107853-08-7
|
|
|
xylinan
|
107853-49-6
|
|
|
ECORII METHYLTRANSFERASE
|
107853-53-2
|
|
|
5-Amino-1-(2-chlorophenyl)-3-methyl-1H-pyrazole-4-carbonitrile
|
107856-31-5
|
C11H9ClN4
|
|
7,8-epoxy-2,11-cembradiene-4,6-diol
|
107856-75-7
|
C20H34O3
|
|
H-PRO-ASN-OH
|
107856-82-6
|
C9H15N3O4
|
|
2-Methyl-6-(prop-1-en-2-yl)aniline
|
107859-36-9
|
C10H13N
|
|
4-(5-MERCAPTO-1,3,4-THIADIAZOL-2-YLTHIOMETHYL)-BENZOICACID
|
107859-96-1
|
C10H8N2O2S3
|
|
3-(4-HYDROXYMETHYL-PHENYL)-PROPIONIC ACID ETHYL ESTER
|
107859-98-3
|
C12H16O3
|
|
3-(4-CHLOROMETHYL-PHENYL)-PROPIONIC ACID ETHYL ESTER
|
107859-99-4
|
C12H15ClO2
|
|
Cyclohexanecarboxylic acid, 3-acetyl-4-oxo-, ethyl ester
|
107861-64-3
|
C11H16O4
|
|
5,6-Dihydro-4H-pyrrolo[1,2-b]pyrazole
|
107862-65-7
|
C6H8N2
|
|
1-METHYL-2-OXO-3-(2-OXOPROPYL)-2,3-DIHYDRO-1H-INDOL-3-YL ACETATE
|
107864-78-8
|
C14H15NO4
|
|
3-HYDROXY-3-(2-OXO-PROPYL)-1-PROPYL-1,3-DIHYDRO-INDOL-2-ONE
|
107864-79-9
|
C14H17NO3
|
|
3'-AMINO-BIPHENYL-4-OL
|
107865-00-9
|
C12H11NO
|
|
nucleoside oQ
|
107865-20-3
|
C17H23N5O8
|
|
thymopoietin pentapeptide-fluorescein isothiocyanate
|
107865-24-7
|
C51H60N10O14S
|
|
H-ALA-ALA-ALA-TYR-ALA-OH
|
107865-40-7
|
C21H31N5O7
|
|
H-ALA-ALA-ALA-TYR-ALA-ALA-OH
|
107865-42-9
|
C24H36N6O8
|
|
1-ACETYL-1H-1,2,3-TRIAZOLO[4,5-B]PYRIDINE
|
107866-54-6
|
C7H6N4O
|
|
ACETIC ACID 4-(3-HYDROXY-PROPYL)-PHENYL ESTER
|
107866-55-7
|
C11H14O3
|
|
2,3-Diamino-5-trifluoromethylpyridine
|
107867-51-6
|
C6H6F3N3
|
|
Exemestane
|
107868-30-4
|
C20H24O2
|
|
Exemestane Impurity 11
|
107868-36-0
|
C20H23ClO2
|
|
(+)-10-CAMPHORSULFONIMINE
|
107869-45-4
|
C10H15NO2S
|
|
AF 30
|
107869-78-3
|
C10H17NO2
|
|
Quivin
|
107870-05-3
|
C36H56O9
|
|
nephtheoxydiol
|
107870-28-0
|
C15H26O3
|
|
[trans(trans)]-4,4'-Methylenebiscyclohexanol
|
107870-37-1
|
C13H24O2
|
|
(17R,21-alpha)-17,21-Dihydroxy-4-(2-propenyl)ajmalanium bromide
|
107870-71-3
|
C23H31N2O2.Br
|
|
4-Hydroxybutyryl-L-carnitine
|
107870-81-5
|
C11H21NO5
|
|
DEHYDRODICONIFERYL ALCOHOL 4-O-BETA-GLUCOPYRANOSIDE(SH)
|
107870-88-2
|
C26H32O11
|
|
formycin triphosphate-terbium complex
|
107870-98-4
|
C10H13N5O13P3Tb
|
|
(R,R)-Cilastatin
|
107872-23-1
|
C16H26N2O5S
|
|
Cilastatin Sodium
|
107872-24-2
|
C16H26N2O5S
|
|
Cyclopropanecarboxamide, 2-methyl-2-(1-methylethyl)- (9CI)
|
107872-80-0
|
C8H15NO
|
|
Bicyclo[4.1.0]heptane-7-carboxamide, (1alpha,6alpha,7alpha)- (9CI)
|
107872-82-2
|
C8H13NO
|
|
2,2-difluorocyclopropane-1-carboxamide
|
107872-84-4
|
C4H5F2NO
|
|
2,2-DIFLUOROCYCLOPROPANECARBOXYLIC ACID
|
107873-03-0
|
C4H4F2O2
|
|
FOLLICULAR GONADOTROPIN-RELEASING PEPTIDE (HUMAN)
|
107873-08-5
|
C68H94N22O27
|